RED-Institut GmbH
Oldenburg, Germany
Research institute in Oldenburg in Holstein, Schleswig-Holstein
Markt 15, 23758 Oldenburg in Holstein
About RED-Institut GmbH
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at RED-Institut GmbH
During the past decade, RED-Institut GmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
2013-03-01
2017-04-14
Completed
418
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
2015-09-01
2019-11-07
Completed
564
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
2015-11-01
2019-11-19
Completed
500
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials
2016-10-01
2017-10-18
Completed
317
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
2018-06-06
2023-02-17
Terminated
1,054
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at RED-Institut GmbH
According to Clinical.Site data, the most researched conditions in "RED-Institut GmbH" are
"Diabetes Mellitus, Type 1" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "RED-Institut GmbH" in a lesser frequency.
Clinical Trials Intervention Types at RED-Institut GmbH
Most popular intervention types in "RED-Institut GmbH" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gan & Lee Insulin Lispro Injection" (1 trials), "Humalog" (1 trials), "MVA-BN-RSV vaccine" (1 trials) and "Tris Buffered Saline (TBS)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at RED-Institut GmbH
The vast majority of trials in "RED-Institut GmbH" are
2 trials for "All" genders.
Clinical Trials Status at RED-Institut GmbH
Currently, there are NaN active trials in "RED-Institut GmbH".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in RED-Institut GmbH,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in RED-Institut GmbH, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".